Frequency Therapeutics Analysis
FREQDelisted Stock | USD 0.52 0.03 5.45% |
Frequency Therapeutics is overvalued with Real Value of 0.44 and Hype Value of 0.52. The main objective of Frequency Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Frequency Therapeutics is worth, separate from its market price. There are two main types of Frequency Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Frequency Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Frequency Therapeutics is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Frequency Stock trading window is adjusted to America/New York timezone.
Frequency |
Frequency Stock Analysis Notes
About 14.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Frequency Therapeutics recorded a loss per share of 1.9. The entity had not issued any dividends in recent years. Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people. To learn more about Frequency Therapeutics call the company at 781 315-4600 or check out www.frequencytx.com.Frequency Therapeutics Investment Alerts
Frequency Therapeutics is not yet fully synchronised with the market data | |
Frequency Therapeutics has some characteristics of a very speculative penny stock | |
Frequency Therapeutics has a very high chance of going through financial distress in the upcoming years | |
Net Loss for the year was (81.58 M) with loss before overhead, payroll, taxes, and interest of (42.02 M). | |
Frequency Therapeutics currently holds about 111.02 M in cash with (58.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Frequency Therapeutics Upcoming and Recent Events
14th of November 2023 Upcoming Quarterly Report | View | |
8th of March 2024 Next Financial Report | View | |
30th of September 2023 Next Fiscal Quarter End | View | |
8th of March 2024 Next Fiscal Year End | View | |
30th of June 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Frequency Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.94 M.Frequency Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Frequency Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Frequency Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Frequency Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Frequency Therapeutics Outstanding Bonds
Frequency Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Frequency Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Frequency bonds can be classified according to their maturity, which is the date when Frequency Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
FRESLN 425 02 OCT 50 Corp BondUS358070AB61 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View |
Frequency Therapeutics Predictive Daily Indicators
Frequency Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Frequency Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Frequency Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Frequency Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Frequency shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Frequency Therapeutics. By using and applying Frequency Stock analysis, traders can create a robust methodology for identifying Frequency entry and exit points for their positions.
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a persons innate regenerative potential to restore function. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts. Frequency Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Frequency Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Frequency Stock
If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |